Journal article
Adjuvant bisphosphonate use in patients with early stage breast cancer: a physician survey
Abstract
PurposeDespite the increasing use of adjuvant bone-modifying agents (BMAs) such as zoledronate and clodronate in the treatment of patients with early stage breast cancer (EBC), little is known about real world practice patterns. A physician survey was performed to address this deficit and determine interest in clinical trials of alternative strategies for BMA administration.MethodsCanadian oncologists treating patients with EBC were surveyed …
Authors
McGee S; Alzahrani M; Vandermeer L; Cole K; Larocque G; Awan A; Hutton B; Pond G; Saunders D; Clemons M
Journal
Breast Cancer Research and Treatment, Vol. 187, No. 2, pp. 477–486
Publisher
Springer Nature
Publication Date
June 2021
DOI
10.1007/s10549-021-06147-1
ISSN
0167-6806